#STOP2030 at a glance! ▶ Discover our project and meet the partners with our newly launched presentation video. All you need to know about our novel co-formulation for #STH in under 5 minutes — watch now! https://t.co/TBItcsNcpQ

This effort, carried out by the STOP2030 Consortium, aims to improve how diseases affecting more than 1.5 billion people are tackled, and to help endemic countries reach their control targets.

Alejandro Krolewiecki, our PI, will give a pitch on the innovations behind the combination of these two drugs: a new dosing strategy that simplifies logistics, enabling the control of more species, all in a one-per-person tablet that dissolves with saliva.

Today we’re presenting our fixed-dose co-formulation of ivermectin and albendazole (FDC) at the Innovation Fair 2025 in Brussels — an event that brings together innovation ecosystems from Europe, Africa, and the Mediterranean.

A glimpse into the new funding models for #NTDs R&D 📊 As funding drops, agencies and governments are exploring new approaches to ensure sustainable support for innovation and disease control. Read it here

Improve #NTD programs through social and behavioural change. The NTD NGO Network has released a quick guide to help organisations develop effective, sustainable, and context-appropriate strategies for #NTDcontrol and elimination. Check it out here:

To improve the lives and health of affected communities, a new treatment needs to be accepted, accessible and effectively implemented. That is why we work to gather extra evidence beyond safety and efficacy. Discover more on our website

Under the REALISE study, we aim to treat ~20,000 people in Ghana and Kenya, thanks to our partners @_GHSofficial and @KEMRI_Kenya. The evidence we obtain will be crucial to advancing the FDC and making it available to countries around the world.

Patients in several schools have started receiving treatment, either the FDC or (in the control group) single-dose albendazole. Several years of collaborative work are behind this significant moment for our Consortium.

The REALISE study, our clinical trial to evaluate the safety in large populations of our fixed-dose coformulation of ivermectin and albendazole (FDC), has reached an important milestone.

Quick recap from #EDCTPForum2025! Grateful to join this vital meeting advancing the fight against #NTDs. 🩺 Alejandro Krolewiecki spoke on behalf of STOP2030 among many key voices driving change. 🌍

Last week, @DrJulieJ was proud to participate in @MundoSano 's 1st annual Global Health conference in Madrid! She spoke to challenges in NTD elimination programs and solutions such as @stop2030project novel fixed-dose coformulation of ivermectin and albendazole for STH. #beatNTDs

🚀 Great news! The @EMA_News has issued a positive opinion for a new treatment for parasitic worm infections! 🤝 This achievement is the result of a decade-long collaboration between @MundoSano, @InsudPharma and @EDCTP . 🔗Check the article https://t.co/HvEB5HOaZT

According to the latest WHO’s progress report, more than half of the school-aged children in need of STH treatments received coverage by preventive #chemotherapy campaigns in 2023. That’s over 354 million children treated all over the world!

Discover our co-formulation 💊 Fixed-dose, mouth-dissolving and easy to administer 🥭 Mango-flavoured 〰 Covers all STH species considered in WHO’s Roadmap 📋 Proven efficacy and safety 📦 And getting ready for implementation Stay tuned for the start of our phase IV trial!

Our partners at @_GHSofficial recently hosted a key stakeholder meeting towards the implementation of paediatric #praziquantel against #schistosomiasis. Our colleague Dr. Joseph Opare shares valuable insights on the impact and next steps

Our most important results to date, explained in under 2 min 🎬 Our phase II-III clinical trial ALIVE demonstrated our co-formulation is safe, and has superior efficacy against more species than the current standard. See why it matters 👇

86 countries required preventive chemotherapy for soil-transmitted #helminths in 2023 💊 According to the latest Progress Report published by WHO, over 800 millionchildren worldwide needed treatment for #parasiticworms. Get the data in detail here

Innovations in #NTDcontrol are constantly emerging, particularly in technology. But how effective are these tools? These researchers have explored how advancements in #AI, robotics, and diagnostics are being tested and implemented in Africa

#Strongyloides stercoralis was the last species to be included as a soil-transmitted helminth by WHO. What sets it apart? 🔬 Requires a different diagnostic technique (Baermann) 🔁 Presents a unique life cycle 💊 And its treatment of choice is #ivermectin

2025 marks the 5️⃣0️⃣-year anniversary of the discovery of #ivermectin, an essential drug to treat many #NTDs, including #strongyloidiasis A fixed-dose strategy for ivermectin can simplify treatment while reducing the risk of underdosing. Read our story